UK markets closed
NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.30 -0.08 (-0.10%) GOLD FUTURES
2,323.10 -1.10 (-0.05%) DOW
38,884.26 +31.99 (+0.08%) Bitcoin GBP
50,191.89 -542.00 (-1.07%)
Northwest Biotherapeutics, Inc. (NBYB.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 02:36PM CEST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 500.03M |
| Enterprise value | 540.41M |
| Trailing P/E | 80.26 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 253.01 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 279.71 |
| Enterprise value/EBITDA | -9.72 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.70 |
| 52-week change 3 | -18.80% |
| S&P500 52-week change 3 | 25.77% |
| 52-week high 3 | 1.0200 |
| 52-week low 3 | 0.3660 |
| 50-day moving average 3 | 0.4696 |
| 200-day moving average 3 | 0.5820 |
Share statistics
| Avg vol (3-month) 3 | 1.24k |
| Avg vol (10-day) 3 | 987 |
| Shares outstanding 5 | 1.2B |
| Implied shares outstanding 6 | 1.23B |
| Float 8 | 1.11B |
| % held by insiders 1 | 9.28% |
| % held by institutions 1 | 0.25% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -3,402.70% |
Management effectiveness
| Return on assets (ttm) | -117.23% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 1.93M |
| Revenue per share (ttm) | 0.00 |
| Quarterly revenue growth (yoy) | -25.50% |
| Gross profit (ttm) | N/A |
| EBITDA | -53.98M |
| Net income avi to common (ttm) | -64.37M |
| Diluted EPS (ttm) | -0.0600 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 2.13M |
| Total cash per share (mrq) | 0 |
| Total debt (mrq) | 45.56M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.09 |
| Book value per share (mrq) | -0.06 |
Cash flow statement
| Operating cash flow (ttm) | -53.64M |
| Levered free cash flow (ttm) | -118.13M |
© 2024 Yahoo. All rights reserved.